Work

Incremental direct healthcare expenditures of valvular heart disease in the USA

Year: 2019

Type: article

Abstract: Aim: To quantify the healthcare expenditures for valvular heart disease (VHD) in the USA. Patients & methods: Direct annual incremental healthcare expenditures were estimated using multiple logistic and linear regression models. Results were stratified by age cohorts (18–64 years, ≥65 and ≥75 years) and disease status: symptomatic aortic valve disease (AVD), asymptomatic AVD, symptomatic mitral valve disease (MVD) and asymptomatic MVD. Results: A total of 1463 VHD patients were identified. The overall aggregated incremental direct expenditures were $56.62 billion ($26.48 billion for patients ≥75 years). Individuals ≥75 years with symptomatic AVD had the largest incremental effect on annual, per-patient healthcare expenditure of $30,949. The annualized incremental costs of VHD were greatest for individuals ≥75 years with AVD. Conclusion: Identification of VHD at an earlier stage may reduce the economic burden.

Source: Journal of Comparative Effectiveness Research

DOI: 10.2217/cer-2019-0007

Authors: Peter J Mallow, Jie Chen, Matt Moore, Candace Gunnarsson, John A Rizzo

Institutions: Xavier University, University of Maryland, College Park, Edwards Lifesciences (United States), Clinical Trial and Consulting, Stony Brook University

Language: English

Topic: Cardiac Valve Diseases and Treatments

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

OpenAlex ID: W2969535170

FWCI: 0.164

Cites: 33

Cited by: 8

Related to: 10